MedTrace Logo

PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial

NCT01652404 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2012-07-30

No results posted yet for this study

Summary

The purpose of this study is to give conclusive evidence on whether serial PCT (Procalcitonin) measurements can facilitate individual decision-making and shorten antibiotic treatment duration in patients with sepsis in the pediatric ICU (Intensive Care Unit).

Conditions

Interventions

BEHAVIORAL

Procalcitonin-guided treatment

The antibiotics duration will be determined by the serum procalcitonin level at day 5, 7 and 9.

BEHAVIORAL

Conventional treatment

The antibiotics duration will be determined by treating physician.

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Hunan Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Chien-Chang Lee, MD, MSc · National Taiwan University Hospital

  • Yi-Min Zhu, BSc · Hunan Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01652404 on ClinicalTrials.gov